A long-wavelength fluorescent substrate for continuous fluorometric determination of α-mannosidase activity: Resorufin α-d-mannopyranoside

Analytical Biochemistry

Volumn 399, Issue 1, 2010, Pages 7-12

  Coleman, Daniel J ^a   Kuntz, Douglas A ^b   Venkatesan, Meenakshi ^b   Cook, Gabriele M ^a   Williamson, Staci P ^a   Rose, David R ^b,c   Naleway, John J ^a  

^a UNIVERSITY OF OREGON   (United States)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Continuous fluorescent enzyme assay; DGMII; Drosophila melanogaster mannosidase II; Fluorogenic substrate; GMII; Golgi mannosidase II; Kinetic assay; Res Man; Resorufin d mannopyranoside

Indexed keywords

ENZYMES; PH;

DGMII; ENZYME ASSAYS; FLUOROGENIC SUBSTRATE; GMII; KINETIC ASSAY; MANNOSIDASE; RESORUFIN;

FLUORESCENCE;

ALPHA MANNOSIDASE; CARBOHYDRATE DERIVATIVE; RECOMBINANT ENZYME; RESORUFIN ALPHA DEXTRO MANNOPYRANOSIDE; SWAINSONINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER THERAPY; CONTROLLED STUDY; DROSOPHILA; DRUG SCREENING; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITOR INTERACTION; ENZYME KINETICS; ENZYME MECHANISM; FLUORESCENCE ANALYSIS; FLUOROMETRY; GOLGI COMPLEX; HIGH THROUGHPUT SCREENING; INSECT CELL; NONHUMAN; PRIORITY JOURNAL; RELIABILITY;

DROSOPHILA MELANOGASTER;

EID: 77649178895     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2009.11.039     Document Type: Article

References (28)

1. Bernacki R.J., Niedbala M.J., Korytnyk W. Glycosidases in cancer and invasion. Cancer Metastasis Rev. 1985, 4:81-101.
2. Dennis J.W., Granovsky M., Warren C.E. Glycoprotein glycosylation and cancer progression. Biochim. Biophys. Acta 1999, 1473:21-34.
3. Hakomori S. Glycosylation defining cancer malignancy: new wine in an old bottle. Proc. Natl. Acad. Sci. USA 2002, 99:10231-10233.
4. Dube D.H., Bertozzi C.R. Glycans in cancer and inflammation: potential for therapeutics and diagnostics. Natl. Rev. Drug Discov. 2005, 4:477-488.
5. Goss P.E., Baker M.E., Carver J.P., Dennis J.W. Inhibitors of carbohydrate processing: a new class of anticancer agents. Clin. Cancer Res. 1995, 1:935-944.
6. Goss P.E., Reid C.L., Bailey D., Dennis J.W. Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignancies. Clin. Cancer Res. 1997, 3:1077-1086.
7. Harpaz N., Schachter H. Control of glycoprotein synthesis: Processing of asparagines-linked oligosaccharides by one or more rat liver Golgi α-d-mannosidases dependent on the prior action of UDP-N-acetylglucosamine: α-d-Mannoside β-2-N-acetylglucosaminyltransferase I. J. Biol. Chem. 1980, 255:4894-4902.
8. Moremen K.W., Touster O., Robbins P.W. Novel purification of the catalytic domain of Golgi α-mannosidase II: characterization and comparison with the intact enzyme. J. Biol. Chem. 1991, 66:16876-16885.
9. Broquist H.P. The indolizidine alkaloids, slaframine and swainsonine: contaminants in animal forages. Annu. Rev. Nutr. 1985, 5:391-409.
10. Tulsiani D.R., Broquist H.P., James L.F., Touster O. Production of hybrid glycoproteins and accumulation of oligosaccharides in the brain of sheep and pigs administered swainsonine or locoweed. Arch. Biochem. Biophys. 1988, 264:607-617.
11. van den Elsen J.M., Kuntz D.A., Rose D.R. Structure of Golgi α-mannosidase II: a target for inhibition of growth and metastasis of cancer cells. EMBO J. 2001, 20:3008-3017.
12. Numao S., Kuntz D.A., Withers S.G., Rose D.R. Insights into the mechanism of Drosophila melanogaster Golgi α-mannosidase through the structural analysis of covalent reaction intermediates. J. Biol. Chem. 2003, 278:48074-48083.
13. Zhong W., Kuntz D.A., Ember B., Singh H., Moremen K.W., Rose D.R., Boons G.-J. Probing the substrate specificity of Golgi α-mannosidase II using synthetic oligosaccharides and a catalytic nucleophile mutant. J. Am. Chem. Soc. 2008, 13:8975-8983.
14. Shah N., Kuntz D.A., Rose D.R. Golgi α-mannosidase II cleaves two sugars sequentially in the same catalytic site. Proc. Natl. Acad. Sci. USA 2008, 105:9570-9575.
15. Rabouille C., Kuntz D.A., Lockyer A., Watson R., Signorelli T., Rose D.R., Van den Heuvel D.B., Roberts M. The Drosophila GMII gene encodes a Golgi α-mannosidase II. J. Cell Sci. 1999, 112:3319-3330.
16. Vázquez-Reyna A.B., Bálcazar-Orozco R., Flores-Carreón A. Biosynthesis of glycoproteins in Candida albicans: Biochemical characterization of a soluble α-mannosidase. FEMS Microbiol. Lett. 1993, 106:321-326.
17. Chernoglazov V.M., Jafarova A.N., Klyosov A.A. Continuous photometric determination of endo-1, 4,-β-d-cellobioside as a substrate. Anal. Biochem. 1984, 138:481-487.
18. H. Sa Van, Extracting organic compounds from aqueous solutions, European patent EP0561760 (1993).
19. Gallego del Sol F., Gomez J., Hoos S., Nagano C.S., Cavada B.S., England P., Calvete J.J. Energetics of 5-bromo-4-chloro-3-indolyl α-d-mannose binding to the Parkia platycephala seed lectin and its use for MAD phasing. Acta Cryst. F 2005, 61:326-331.
20. R.A. Jefferson. Plant promoter α-glucuronidase gene construct, U.S. patent 5,268,463 (1993).
21. Coleman D.J., Studler M.J., Naleway J.J. A long-wavelength fluorescent substrate for continuous fluorometric determination of cellulase activity: resorufin β-d-cellobioside. Anal. Biochem. 2007, 371:146-153.
22. Goggin K.D., Hammen P.D., Kuntson K.L., Lambert J.F., Walinsky S.W., Watson H.A. Commercial synthesis of β-d-cellobiosyl bromide heptaacetate. J. Chem. Technol. Biotechnol. 2004, 60:253-256.
23. R.P. Haugland, J.J. Naleway, Y.Z. Zhang, Lipophilic fluorescent glycosidase substrates, U.S. patent 5,208,148 (1993).
24. Wimmer Z., Pechová L., Šaman D. Koenigs-Knorr synthesis of cycloalkyl glycosides. Molecules 2004, 9:902-912.
25. Zemplen G. Abbau der reduzierenden Biosen: VII. Konstitutions-Ermittlung der Maltose. Ber. Dtsch. Chem. Ges. B 1927, 60:1555.
26. Zemplen G., Pacsu E. Über die Verseifung acetylierter Zucker und verwandter Substanzen. Ber. Dtsch. Chem. Ges. 1929, 62:1613-1614.
27. Fiaux H., Kuntz D.A., Hoffman D., Janzer R.C., Gerber-Lemaire S., Rose D.R., Juillerat-Jeanneret L. Functionalized pyrrolidine inhibitors of human type II α-mannosidases as anti-cancer agents: optimizing the fit to the active site. Bioorg. Med. Chem. 2008, 16:7337-7346.
28. Ryder A.G., Power S., Glynn T.J. Fluorescence lifetime based pH sensing using resorufin. Proc. SPIE 2003, 4876:827-835.